METX.CN Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: February 03, 2026
Report Source: 2026 1st Quarter Report
ME Therapeutics Holdings Inc. Stock Analysis METX.CN
Canada N/A Micro Cap Report: ME Therapeutics Holdings, Inc. provides biotechnology and pharmaceutical services. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2023-10-12. The Company’s focus is on overcoming the suppressive effects of a class of immune cells called myeloid cells to enhance anti-cancer immunity. The Company’s lead candidate is a novel high affinity antibody drug that targets a key protein involved in the generation of suppressive myeloid cells. In addition to its antibody drug candidate program, the Company is also developing a novel small molecule prodrug candidate designed to specifically target suppressive myeloid cells in the tumor environment. The firm has initiated design and testing of two new mRNA-based cancer therapeutic drug candidates.
Read More ME Therapeutics Holdings Inc (METX.CN) Chart
Key Statistics of ME Therapeutics Holdings Inc (METX.CN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD3.70Volume
800.00P/E Ratio (TTM)
-52 Week Range
Market Cap
73.83MAvg. Volume
800.00Dividend Yield
-Financial Metrics & Statements of ME Therapeutics Holdings Inc (METX.CN)
FAQ's for ME Therapeutics Holdings Inc (METX.CN)
- According to Musaffa’s Shariah screening methodology, ME Therapeutics Holdings Inc (METX.CN) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.